奥翔药业(603229.SH)发布半年度业绩，归母净利润1.69亿元，同比下降5.83%

Group 1 - The company reported a revenue of 482 million yuan for the first half of 2025, representing a year-on-year decrease of 2.14% [1] - The net profit attributable to the parent company was 169 million yuan, down 5.83% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 151 million yuan, reflecting a year-on-year decline of 12.29% [1] - The basic earnings per share stood at 0.20 yuan [1]